| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Cumberland Pharmaceuticals Inc (CPIX) has 10 insiders with recent SEC Form 4 filings, including 196 buys and 0 sells. CPIX is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 568.0K | $2.75M | - | |
| Dir | 298.3K | $1.45M | - | |
| Dir | 63.7K | $308.7K | - | |
| Dir | 46.9K | $227.3K | - | |
| Dir | 35.1K | $170.3K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 30, 2022 | Krogulski Kenneth54 | Director | Buy | 2,205 | $2.37 | $5,226.90 | - | +1.3% | -27.8% | |
| Nov 30, 2022 | Galante Joseph C47 | Director | Buy | 1,365 | $2.37 | $3,235.70 | +0.1% | +1.3% | -27.8% | |
| Nov 30, 2022 | Young Caroline51 | Director | Buy | 420 | $2.37 | $995.60 | +0.1% | +1.3% | -27.8% | |
| Nov 30, 2022 | Jones James52 | Director | Buy | 651 | $2.37 | $1,543.18 | +0.1% | +1.3% | -27.8% | |
| Oct 31, 2022 | Young Caroline51 | Director | Buy | 500 | $2.49 | $1,247.40 | +0.1% | +9.8% | -19.5% | |
| Oct 31, 2022 | Jones James52 | Director | Buy | 775 | $2.49 | $1,933.47 | +0.1% | +9.8% | -19.5% | |
| Oct 31, 2022 | Galante Joseph C47 | Director | Buy | 1,625 | $2.49 | $4,054.05 | +0.1% | +9.8% | -19.5% | |
| Oct 31, 2022 | Krogulski Kenneth54 | Director | Buy | 2,625 | $2.49 | $6,548.85 | - | +9.8% | -19.5% | |
| Sep 27, 2022 | Jones James52 | Director | Buy | 186 | $2.54 | $472.75 | +0.1% | -3.7% | -22.0% | |
| Sep 27, 2022 | Krogulski Kenneth54 | Director | Buy | 630 | $2.54 | $1,601.25 | - | -3.7% | -22.0% |